Abstract Purpose The PET tracer [18F] florbetapir is a specific fibrillar amyloid-beta (Aβ)
biomarker. During the late scan phase (> 40 min), it provides pathological information about
Aβ status. Early scan phase (0–10 min) can provide FDG-'like'information. The current
investigation tested the feasibility of using florbetapir as a dual-phase biomarker in
behavioural variant frontotemporal dementia (bvFTD). Methods Eight bvFTD patients
underwent [18F] florbetapir and [18] FDG-PET scans. Additionally, ten healthy controls and …

Abstract Purpose: The PET tracer [18F] florbetapir is a specific fibrillar amyloid-beta (Aβ)
biomarker. During the late scan phase (> 40 min), it provides pathological information
about Aβ status. Early scan phase (0-10 min) can provide FDG-'like'information. The current
investigation tested the feasibility of using florbetapir as a dual-phase biomarker in
behavioural variant frontotemporal dementia (bvFTD). Methods: Eight bvFTD patients
underwent [18F] florbetapir and [18] FDG-PET scans. Additionally, ten healthy controls and …